Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 19/20 | 0.45 |
| ▸ | PIK3CG | P48736 | 14/20 | 0.45 |
| ▸ | PIK3R1 | P27986 | 11/20 | 0.45 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.45 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.45 |
| ▸ | HTR2A | P28223 | 1/20 | 0.45 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.45 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.45 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.45 |
| ▸ | PIK3R2 | O00459 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16116761 | 0.86 | PIK3CD (0.42) | PIK3CDPIK3CGPIK3R1ABCB11TBXA2R | |
| SCHEMBL16345901 | 0.85 | PIK3CD (0.41) | PIK3CDPIK3CGPIK3R1ABCB11TBXA2R | |
| SCHEMBL14649255 | 0.84 | PIK3CD (0.44) | PIK3CDPIK3CGPIK3R1ABCB11TBXA2R | |
| SCHEMBL16346401 | 0.84 | PIK3CD (0.42) | PIK3CDPIK3CGPIK3R1ABCB11TBXA2R | |
| SCHEMBL2599468 | 0.84 | PIK3CD (0.42) | PIK3CDPIK3CGPIK3R1ABCB11TBXA2R | |
| SCHEMBL14726533 | 0.81 | PIK3CD (0.43) | PIK3CDPIK3CGPIK3R1ABCB11TBXA2R | |
| SCHEMBL16591273 | 0.79 | PIK3CD (0.54) | PIK3CDPIK3CGPIK3R1ABCB11TBXA2R | |
| SCHEMBL16386791 | 0.78 | PIK3CD (0.53) | PIK3CDPIK3CGPIK3R1ABCB11TBXA2R | |
| SCHEMBL30343572 | 0.77 | PIK3CD (0.54) | PIK3CDPIK3CGPIK3R1ABCB11TBXA2R | |
| SCHEMBL29440942 | 0.77 | PIK3CD (0.54) | PIK3CDPIK3CGPIK3R1ABCB11TBXA2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3441392-A1 | A PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION | Intellikine, LLC (US) | 2019-02-13 | — | — | EP | disclosed |